Kura Oncology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $646.68 million, with shareholders equity totaling $17.96 million.
The company employs approximately 60 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Kura Oncology Inc. reported $79.31 million in revenue, generating net income of $-292.87 million.
Key financial metrics include a P/E ratio of -2.21, a price-to-book (P/B) ratio of 36.01, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker KURA.